APA-话题@MedSci

#APA#

153篇内容 | 3640人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1338155, encodeId=a7f1133815509, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=NEJM：Niraparib可显著延长铂敏感的复发性卵巢癌患者无进展生存期, objectType=article, longId=79605, objectId=925ae9605d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=925ae9605d0, replyNumber=0, likeNumber=56, createdTime=2016-10-10, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=925ae9605d0, moduleTitle=NEJM：Niraparib可显著延长铂敏感的复发性卵巢癌患者无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=925ae9605d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338154, encodeId=ca3c133815412, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=抗癌新药Niraparib轰动全球，告诉你到底是个啥？, objectType=article, longId=71907, objectId=b6d8e190782, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6d8e190782, replyNumber=0, likeNumber=52, createdTime=2016-07-02, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6d8e190782, moduleTitle=抗癌新药Niraparib轰动全球，告诉你到底是个啥？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6d8e190782)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338153, encodeId=b141133815331, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=亚太血管学术联盟（APA）澳门国际论坛暨2016澳门卫生局医生协会国际学术年会圆满召开, objectType=article, longId=71636, objectId=9004e1636c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9004e1636c2, replyNumber=0, likeNumber=49, createdTime=2016-06-28, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9004e1636c2, moduleTitle=亚太血管学术联盟（APA）澳门国际论坛暨2016澳门卫生局医生协会国际学术年会圆满召开, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9004e1636c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338152, encodeId=7034133815263, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=亚太血管学术联盟（APA）澳门国际论坛暨2016澳门卫生局医生协会国际学术年会, objectType=article, longId=71336, objectId=f7d6e133687, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7d6e133687, replyNumber=0, likeNumber=0, createdTime=2016-06-22, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7d6e133687, moduleTitle=亚太血管学术联盟（APA）澳门国际论坛暨2016澳门卫生局医生协会国际学术年会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7d6e133687)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338151, encodeId=7d47133815159, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=亚太血管学术联盟（APA）澳门国际论坛暨2016澳门卫生局医生协会国际学术年会(第三轮通知), objectType=article, longId=70655, objectId=0367e0655b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0367e0655b5, replyNumber=0, likeNumber=56, createdTime=2016-06-15, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0367e0655b5, moduleTitle=亚太血管学术联盟（APA）澳门国际论坛暨2016澳门卫生局医生协会国际学术年会(第三轮通知), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0367e0655b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338150, encodeId=2275133815087, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=ASCO 2016：奥拉帕利（Olaparib）全面开战：卵巢癌、乳腺癌、胃癌, objectType=article, longId=70433, objectId=5298e043346, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5298e043346, replyNumber=0, likeNumber=0, createdTime=2016-06-12, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5298e043346, moduleTitle=ASCO 2016：奥拉帕利（Olaparib）全面开战：卵巢癌、乳腺癌、胃癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5298e043346)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338149, encodeId=c28213381493c, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=APA 2016：暴饮暴食症筛查的临床应用研究, objectType=article, longId=69908, objectId=cc206990862, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc206990862, replyNumber=0, likeNumber=62, createdTime=2016-06-05, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc206990862, moduleTitle=APA 2016：暴饮暴食症筛查的临床应用研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc206990862)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338148, encodeId=37cd133814840, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=阿斯利康降糖药saxa/dapa（沙格列汀/达格列净）获欧盟CHMP支持批准，将成欧洲DPP-4i/SGLT-2i降糖药, objectType=article, longId=69403, objectId=04f76940319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04f76940319, replyNumber=0, likeNumber=73, createdTime=2016-05-30, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04f76940319, moduleTitle=阿斯利康降糖药saxa/dapa（沙格列汀/达格列净）获欧盟CHMP支持批准，将成欧洲DPP-4i/SGLT-2i降糖药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04f76940319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338147, encodeId=38ee133814e13, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=【ASCO 2016】预告：奥拉帕利（Olaparib）和BRCA突变相关研究, objectType=article, longId=69354, objectId=61d4693540e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61d4693540e, replyNumber=0, likeNumber=51, createdTime=2016-05-29, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61d4693540e, moduleTitle=【ASCO 2016】预告：奥拉帕利（Olaparib）和BRCA突变相关研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61d4693540e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338146, encodeId=909e133814664, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=APA 2016：ECT可有效治疗精神分裂症，但仍需进一步的研究, objectType=article, longId=69120, objectId=c6bf69120c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6bf69120c0, replyNumber=0, likeNumber=60, createdTime=2016-05-26, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6bf69120c0, moduleTitle=APA 2016：ECT可有效治疗精神分裂症，但仍需进一步的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6bf69120c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338145, encodeId=12ba1338145a5, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=STM：birinapant和emricasan新的药物组合在治疗白血病上显示成功的希望, objectType=article, longId=68846, objectId=e02468846d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e02468846d4, replyNumber=0, likeNumber=50, createdTime=2016-05-23, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e02468846d4, moduleTitle=STM：birinapant和emricasan新的药物组合在治疗白血病上显示成功的希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e02468846d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338144, encodeId=ef151338144af, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=APA 2016：养狗可以很好地改善创伤后应激障碍患者的精神状态, objectType=article, longId=68517, objectId=88e66851e9b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88e66851e9b, replyNumber=0, likeNumber=103, createdTime=2016-05-19, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88e66851e9b, moduleTitle=APA 2016：养狗可以很好地改善创伤后应激障碍患者的精神状态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88e66851e9b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338143, encodeId=ee2f133814353, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=美国精神病学会（APA）2016年会会议嘉宾、议程早知道, objectType=article, longId=68083, objectId=d2726808307, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2726808307, replyNumber=0, likeNumber=59, createdTime=2016-05-14, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2726808307, moduleTitle=美国精神病学会（APA）2016年会会议嘉宾、议程早知道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2726808307)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338142, encodeId=5104133814248, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=lapatinib以及trastuzumab组合可以11天内消灭特定乳腺癌, objectType=article, longId=64864, objectId=a5bf6486466, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5bf6486466, replyNumber=0, likeNumber=0, createdTime=2016-03-17, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5bf6486466, moduleTitle=lapatinib以及trastuzumab组合可以11天内消灭特定乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5bf6486466)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338141, encodeId=d607133814119, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=Circulation：Vorapaxar可减少外周动脉疾病（PAD）患者发生急性肢体缺血（ALI）, objectType=article, longId=62863, objectId=9eb76286349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9eb76286349, replyNumber=0, likeNumber=53, createdTime=2016-02-03, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9eb76286349, moduleTitle=Circulation：Vorapaxar可减少外周动脉疾病（PAD）患者发生急性肢体缺血（ALI）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9eb76286349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338140, encodeId=91a313381406f, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=APA 2015：为何足球前锋更易罹患心脏病（附盘点）, objectType=article, longId=58734, objectId=f10658e342d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f10658e342d, replyNumber=0, likeNumber=69, createdTime=2015-11-13, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f10658e342d, moduleTitle=APA 2015：为何足球前锋更易罹患心脏病（附盘点）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f10658e342d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338139, encodeId=f2f71338139b9, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=APA 2015：没事多听听音乐，有助于预防癫痫发作, objectType=article, longId=54671, objectId=2206546e1c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2206546e1c3, replyNumber=0, likeNumber=86, createdTime=2015-08-12, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2206546e1c3, moduleTitle=APA 2015：没事多听听音乐，有助于预防癫痫发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2206546e1c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338138, encodeId=9bbb13381382b, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=APAC：保健药真的能保健么？, objectType=article, longId=54623, objectId=664454623e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=664454623e3, replyNumber=0, likeNumber=67, createdTime=2015-08-11, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=664454623e3, moduleTitle=APAC：保健药真的能保健么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=664454623e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338137, encodeId=114e133813eae, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=APASL乙型肝炎指南更新版解读, objectType=article, longId=51923, objectId=3c52519231b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c52519231b, replyNumber=0, likeNumber=54, createdTime=2015-06-12, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c52519231b, moduleTitle=APASL乙型肝炎指南更新版解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c52519231b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338136, encodeId=072113381361c, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, objectTitle=Ardelyx重磅药物tenapanor（NHE3受体抑制剂）二期临床试验失利, objectType=article, longId=50383, objectId=d6d7503835f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6d7503835f, replyNumber=0, likeNumber=60, createdTime=2015-05-09, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6d7503835f, moduleTitle=Ardelyx重磅药物tenapanor（NHE3受体抑制剂）二期临床试验失利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6d7503835f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

APA

2020-05-29

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

NEJM：Niraparib可显著延长铂敏感的复发性卵巢癌患者无进展生存期

2016-10-10

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

抗癌新药Niraparib轰动全球，告诉你到底是个啥？

2016-07-02

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

亚太血管学术联盟（APA）澳门国际论坛暨2016澳门卫生局医生协会国际学术年会圆满召开

2016-06-28

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

亚太血管学术联盟（APA）澳门国际论坛暨2016澳门卫生局医生协会国际学术年会

2016-06-22

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

亚太血管学术联盟（APA）澳门国际论坛暨2016澳门卫生局医生协会国际学术年会(第三轮通知)

2016-06-15

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

ASCO 2016：奥拉帕利（Olaparib）全面开战：卵巢癌、乳腺癌、胃癌

2016-06-12

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

APA 2016：暴饮暴食症筛查的临床应用研究

2016-06-05

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

阿斯利康降糖药saxa/dapa（沙格列汀/达格列净）获欧盟CHMP支持批准，将成欧洲DPP-4i/SGLT-2i降糖药

2016-05-30

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

【ASCO 2016】预告：奥拉帕利（Olaparib）和BRCA突变相关研究

2016-05-29

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

APA 2016：ECT可有效治疗精神分裂症，但仍需进一步的研究

2016-05-26

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

STM：birinapant和emricasan新的药物组合在治疗白血病上显示成功的希望

2016-05-23

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

APA 2016：养狗可以很好地改善创伤后应激障碍患者的精神状态

2016-05-19

zhouqu_8 (审核中...)

前往app查看评论内容

#APA#

美国精神病学会（APA）2016年会会议嘉宾、议程早知道

2016-05-14

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

lapatinib以及trastuzumab组合可以11天内消灭特定乳腺癌

2016-03-17

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

Circulation：Vorapaxar可减少外周动脉疾病（PAD）患者发生急性肢体缺血（ALI）

2016-02-03

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

APA 2015：为何足球前锋更易罹患心脏病（附盘点）

2015-11-13

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

APA 2015：没事多听听音乐，有助于预防癫痫发作

2015-08-12

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

APAC：保健药真的能保健么？

2015-08-11

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

APASL乙型肝炎指南更新版解读

2015-06-12

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#APA#

Ardelyx重磅药物tenapanor（NHE3受体抑制剂）二期临床试验失利

2015-05-09

科室
- - 订阅+
  - 更多科室
工具
服务